LASSBio-1835

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLASSBio-1835
Drug Alias NameLASSBio-1835
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptorPhosphodieterase 4
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFederal University of Rio de Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesFederal University of Rio de Janeiro
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A